Lv1
40 积分 2023-12-26 加入
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
1个月前
已完结
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader
1个月前
已完结
Bispecific antibody drug conjugates: Making 1+1>2
1个月前
已完结
The cancer-immunity cycle: Indication, genotype, and immunotype
2个月前
已完结
Trends in the drug target landscape for autoimmune diseases
2个月前
已完结
Cancer Research Communications
8个月前
已完结
A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy
8个月前
已完结
Advances in the treatment of systemic lupus erythematosus
8个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
8个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
9个月前
已完结
皖公网安备34019202002308
